Position in BCAB
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$16,662
-$42,122 QoQ
Shares Held
103,494
0.0% QoQ
Ownership
6.21%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,811,269,626 across 424 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in BCAB
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,662 | 103,494 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $58,784 | 103,494 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $69,369 | 100,828 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $39,927 | 100,828 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $34,986 | 100,828 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $59,585 | 100,822 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $156,254 | 88,781 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $448,734 | 327,544 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,217,553 | 353,940 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $875,498 | 355,894 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $607,511 | 357,360 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,094,334 | 364,778 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $242,273 | 90,401 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $704,409 | 85,383 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $553,283 | 71,855 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $153,280 | 53,783 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $870,355 | 174,071 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,534,341 | 180,048 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $5,187,327 | 176,200 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,236,300 | 147,152 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $6,240,101 | 122,740 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||